Phase I/II trial of preoperative TS-1 + CDDP + radiation therapy for large type 3 or type 4 advanced gastric cancer (OGSG 1205).
Status: Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 12 Oct 2018
Price : $35 *
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Adenocarcinoma; Gastric cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Oct 2018 Planned End Date changed from 31 Oct 2021 to 31 Mar 2019.
- 04 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 22 Jan 2017 Planned End Date changed from 31 Dec 2020 to 31 Oct 2021.